Form 4: Quest Diagnostics SVP Patrick Plewman Reports Stock Transactions
SEC Form 4 Filing
Patrick Plewman, SVP at Quest Diagnostics, reports acquisition and disposition of company stock related to a performance share award.
Summary
- On February 23, 2024, Patrick Plewman, SVP for Diagnostic Services at Quest Diagnostics, reported transactions involving the company's common stock.
- He acquired 2,388 shares at a price of $125.02 related to the settlement of a performance share award dated February 18, 2021.
- He disposed of 869 shares at $125.02 to cover tax withholding obligations arising from the settlement of the performance share award.
- Following these transactions, Plewman beneficially owns 16,415 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency into the actions of key personnel and their holdings in the company.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect insider activity related to compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| February 18, 2021 | Date of the performance share award. |
| February 23, 2024 | Date of stock acquisition and disposition. |
| February 27, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.